Albatroz Therapeutics Secures $3 Million to Develop First-Ever Therapy Blocking a Universal Process Involved in the Growth and Spread of Cancerous Solid Tumors and Arthritic Cartilage Degradation
Funding is amplified by recognition as first Amgen Golden Ticket winner in Singapore SINGAPORE--(BUSINESS WIRE)--Albatroz…